Table 1 Summary of the clinical information of cervical cancer patients included in TCGA database
From: Machine learning-based prediction of survival prognosis in cervical cancer
Characteristics | Cohort (n=307) | |
|---|---|---|
No. | % | |
Age at initial pathologic diagnosis | Â | Â |
Age <= 35 | 56 | 18.24 |
35 < Age <= 60 | 192 | 62.54 |
Age > 60 | 59 | 19.22 |
NA | 0 | 0.00 |
Age began smoking | ||
Age <= 30 | 75 | 24.43 |
Age > 30 | 10 | 3.26 |
NA | 222 | 72.31 |
Neoplasm pathologic margin involved text | ||
Margins free of tumor | 23 | 7.49 |
Others | 17 | 5.54 |
NA | 267 | 86.97 |
Neoplasm pathologic margin involved type | ||
Macroscopic and microscopic parametrial involvement | 10 | 3.26 |
Other location, specify | 40 | 13.03 |
Positive bladder and vaginal margin | 13 | 4.23 |
NA | 244 | 79.48 |
Survival (years) | ||
<= 3 | 55 | 17.92 |
> 3 | 92 | 29.97 |
Loss to follow up < 3 | 160 | 52.12 |
Height (cm) | ||
< 150 | 15 | 4.89 |
150 - 160 | 119 | 38.76 |
160 - 170 | 111 | 36.16 |
>= 170 | 19 | 6.19 |
NA | 43 | 14.01 |
Histological type | ||
Adenosquamous | 6 | 1.95 |
Cervical squamous cell carcinoma | 254 | 82.74 |
Endocervical adenocarcinoma of the usual type | 6 | 1.95 |
Endocervical type of adenocarcinoma | 21 | 6.84 |
Endometrioid adenocarcinoma of endocervix | 3 | 0.98 |
Mucinous adenocarcinoma of endocervical type | 17 | 5.54 |
NA | 0 | 0.00 |
Race | ||
American indian or alaska native | 8 | 2.61 |
Asian | 20 | 6.51 |
Black or african american | 30 | 9.77 |
Native hawaiian or other pacific islander | 2 | 0.65 |
White | 211 | 68.73 |
NA | 36 | 11.73 |
Clinical stage | ||
Stage I - IIa | 189 | 61.56 |
Stage IIb - IVb | 111 | 36.16 |
NA | 7 | 2.28 |
HPV infection | ||
Hpv16 | 172 | 56.03 |
Hpv18 | 39 | 12.70 |
Others | 73 | 23.78 |
NA | 23 | 7.49 |